CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathwaysKiyoko Nakamura, Masahide Ohmichi, Yoshito Terai et al.|Oncology Reports|2017Cited by 117
Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancerYoshimichi Tanaka, Masahide Ohmichi, Yoshito Terai et al.|Cancer Biology & Therapy|2013Cited by 110
The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancerMasaaki Takai, Masahide Ohmichi, Yoshito Terai et al.|Journal of Ovarian Research|2014Cited by 108
Maintenance Treatment with Bevacizumab Prolongs Survival in an<i>In vivo</i>Ovarian Cancer ModelSeiji Mabuchi, Masahide Ohmichi, Yoshito Terai et al.|Clinical Cancer Research|2008Cited by 94
GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancerSatoe Fujiwara, Masahide Ohmichi, Yoshito Terai et al.|Journal of Ovarian Research|2012Cited by 79